Since the association of the gene insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2) and risk of T2DM was founded by the study group of the Wellcome Trust Case Control Consortium (WTCCC), IGF2BP2 has been identified as a notable T2DM candidate gene [6,7,8]. This evidence concerns the gene IGF2BP2 and type 2 diabetes mellitus.